Sofia Nadgauda
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sofia Nadgauda has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
Amani M Nuru-Jeter
Department of Community Health Sciences, School of Public Health, University of California, Berkeley , Berkeley, CA
1 shared publicationConnor D Martz
Department of Population Health Sciences, University of Central Florida, College of Medicine , Orlando, FL
1 shared publicationCristina M Lanata
National Human Genome Research Institute, National Institutes of Health , Bethesda, MD
1 shared publicationDavid H Chae
Department of Social, Behavioral, and Population Sciences, Celia Scott Weatherhead School of Public Health and Tropical Medicine, Tulane University , New Orleans, LA
1 shared publication- Elissa Sarah Epel
Department of Psychiatry and Behavioral Sciences, University of California, San Francisco
1 shared publication - Eloisa Bonfá
Rheumatology Division, Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo (HCFMUSP), São Paulo, SP, Brazil
1 shared publication
Latest Publications
- Open Access
- 6 January 2026
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 220 (1)
Prospective association between leukocyte telomere length and mortality: findings from the Black Women's Experiences Living with Lupus (BeWELL) Study
Leukocyte telomere length (LTL) is a biomarker of replicative history of cells and has been posited to be an indicator of biological aging. LTL may yield insight into immunomodulatory disorders, including systemic lupus erythematosus (SLE), an immune-mediated inflammatory disease that disproportionately affects Black/African American women. This study examined the association between LTL and mortality among 422 Black/African American women in the Black Women's Experiences Living with Lupus (BeWELL) Study. Participants were recruited from metropolitan Atlanta, Georgia, between April 2015 and May 2017 and followed for a mean of 1.98 years (SD = 0.38). LTL was measured as the telomere-to-single copy gene ratio (T/S). Mortality was assessed prospectively. Cox proportional hazards regression models adjusting for sociodemographic, health, and disease characteristics were specified. A total of 19 participants died during the follow-up period. Adjusting for demographic, socioeconomic, and health-related covariates, longer LTL was associated with lower risk of mortality (hazard ratio = 0.13, 95% confidence interval = 0.02, 0.83, P = 0.03). This study is the first to report an association between LTL and subsequent mortality among Black/African American women with SLE. Findings may be particularly relevant for this population, which has been shown to experience severe disease consequences. Future research may further explore LTL in mechanistic studies of SLE and assess the utility of LTL for monitoring disease progression and outcomes.
- 6 January 2026
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 220 (1)
Open AccessProspective association between leukocyte telomere length and mortality: findings from the Black Women's Experiences Living with Lupus (BeWELL) Study
Leukocyte telomere length (LTL) is a biomarker of replicative history of cells and has been posited to be an indicator of biological aging. LTL may yield insight into immunomodulatory disorders, including systemic lupus erythematosus (SLE), an immune-mediated inflammatory disease that disproportionately affects Black/African American women. This study examined the association between LTL and mortality among 422 Black/African American women in the Black Women's Experiences Living with Lupus (BeWELL) Study. Participants were recruited from metropolitan Atlanta, Georgia, between April 2015 and May 2017 and followed for a mean of 1.98 years (SD = 0.38). LTL was measured as the telomere-to-single copy gene ratio (T/S). Mortality was assessed prospectively. Cox proportional hazards regression models adjusting for sociodemographic, health, and disease characteristics were specified. A total of 19 participants died during the follow-up period. Adjusting for demographic, socioeconomic, and health-related covariates, longer LTL was associated with lower risk of mortality (hazard ratio = 0.13, 95% confidence interval = 0.02, 0.83, P = 0.03). This study is the first to report an association between LTL and subsequent mortality among Black/African American women with SLE. Findings may be particularly relevant for this population, which has been shown to experience severe disease consequences. Future research may further explore LTL in mechanistic studies of SLE and assess the utility of LTL for monitoring disease progression and outcomes.